Literature DB >> 20591314

In-Vitro Simulation of NBCA Embolization for Arteriovenous Malformation.

S Inagawa1, H Isoda, H Kougo, S Isogais, H Sakahara.   

Abstract

SUMMARY: Embolization using n-butyl-cyanoacrylate (NBCA) for arteriovenous malformation (AVM) is now a daily practice over the world, but there exists no objective data that can be a basis for discussion or decision-making on the best concentration and injection rate of NBCA mixture. The purpose of this study was to obtain objective data on control and behavior of NBCA mixture with an in vitro simulation system of NBCA embolization for AVM. A nidus model made of a one-ml syringe filled with small beads was connected to a pulsatile flow circuit. A microcatheter was introduced just before the nidus model. Endoluminal pressures proximal and distal to the nidus and flow volume through the nidus were measured. Digital subtraction angiography (DSA) was performed to calculate transit time of the contrast medium (CM) through the nidus. NBCA was injected at various rates with an autoinjector and transit time of NBCA through the nidus was calculated. 27 trials were completed. Transit time of CM through the nidus model is well correlated to flow volume per unit of time through the nidus model. Shorter the transit time, larger was the flow volume per unit of time. The correlation was statistically significant (P < .0001). Though statistical significance was not attained, transit time of NBCA mixture at 50% concentration had a tendency to be correlated to flow volume per unit of time through the nidus, and slower injection of the NBCA mixture led to slower filling of the nidus model. Though this simulation system was artificial and the results should be interpreted carefully, it was shown with this system that transit time of CM through the nidus could be a good index for flow volume per unit of time through the nidus. Also suggested was a possibility to utilize this in vitro system for research and training on NBCA embolization of AVM.

Entities:  

Year:  2004        PMID: 20591314      PMCID: PMC3547376          DOI: 10.1177/159101990300900404

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  12 in total

1.  In vitro models of intracranial arteriovenous fistulas for the evaluation of new endovascular treatment materials.

Authors:  P Gailloud; M Muster; M Piotin; F Mottu; K J Murphy; J H Fasel; D A Rüfenacht
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

2.  Calibrated leak balloon microcatheter: a device for arterial exploration and occlusive therapy.

Authors:  C W Kerber; W O Bank; L D Cromwell
Journal:  AJR Am J Roentgenol       Date:  1979-02       Impact factor: 3.959

3.  Arteriovenous malformation model for training and research.

Authors:  C W Kerber; S T Hecht; K Knox
Journal:  AJNR Am J Neuroradiol       Date:  1997-08       Impact factor: 3.825

4.  MR angiography of aneurysm models of various shapes and neck sizes.

Authors:  H Isoda; R G Ramsey; Y Takehara; M Takahashi; M Kaneko
Journal:  AJNR Am J Neuroradiol       Date:  1997-09       Impact factor: 3.825

5.  High-flow-rate arteriovenous malformation model for simulated therapeutic embolization.

Authors:  W S Bartynski; G V O'Reilly; M D Forrest
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

6.  n-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies.

Authors:  M F Brothers; J C Kaufmann; A J Fox; J P Deveikis
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jul-Aug       Impact factor: 3.825

7.  Modification of cyanoacrylate for therapeutic embolization: preliminary experience.

Authors:  L D Cromwell; C W Kerber
Journal:  AJR Am J Roentgenol       Date:  1979-05       Impact factor: 3.959

8.  Actual behaviour of N-butyl-2-cyanoacrylate (histoacryl) in a blood vessel: a model of the varix.

Authors:  T Suga; T Akamatsu; Y Kawamura; H Saegusa; M Kajiyama; N Nakamura; M Takei; A Matsumoto
Journal:  Endoscopy       Date:  2002-01       Impact factor: 10.093

9.  Hemodynamic aspects of cerebral arteriovenous malformations.

Authors:  H Nornes; A Grip
Journal:  J Neurosurg       Date:  1980-10       Impact factor: 5.115

10.  A teaching and research simulator for therapeutic embolization.

Authors:  C W Kerber; L W Flaherty
Journal:  AJNR Am J Neuroradiol       Date:  1980 Mar-Apr       Impact factor: 3.825

View more
  4 in total

1.  Factors determining the success of endovascular treatments among patients with spinal dural arteriovenous fistulas.

Authors:  I-Chang Su; Karel G terBrugge; Robert A Willinsky; Timo Krings
Journal:  Neuroradiology       Date:  2013-10-10       Impact factor: 2.804

2.  Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.

Authors:  D F Vollherbst; C M Sommer; C Ulfert; J Pfaff; M Bendszus; M A Möhlenbruch
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

3.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

4.  A Computational Framework for Pre-Interventional Planning of Peripheral Arteriovenous Malformations.

Authors:  Gaia Franzetti; Mirko Bonfanti; Cyrus Tanade; Chung Sim Lim; Janice Tsui; George Hamilton; Vanessa Díaz-Zuccarini; Stavroula Balabani
Journal:  Cardiovasc Eng Technol       Date:  2021-10-05       Impact factor: 2.305

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.